Press Release Source: Primary Technology, LLC
Primary Technology, LLC Receives Notice of Allowance from the U.S.P.T.O. for Second Intense Pulsed Light Patent
Thursday March 6, 11:10 am ET
TAMPA, Fla., March 6 /PRNewswire/ -- Primary Technology, LLC, a privately held Florida corporation specializing in cosmetic medical device manufacturing, announced today that the U.S. Patent and Trademark Office (USPTO) has given notice of allowance to a second Intense Pulsed Light technology patent.
Primary Technology's intense pulsed light aesthetic medical devices are currently used to remove benign pigmented and vascular lesions as well as perform hair removal. This new patent, which encompasses multiple dermatological treatments, will allow Primary Technology to create whole new product lines in the "cosmetic" and "medically necessary" arenas. These new devices will include treatments for wrinkle reduction, skin smoothing, psoriasis, and acne to name only a few.
According to Anthony Davis, Executive Vice President of Primary Technology, this notice is a huge event for the company and technology. "In the aesthetic medical industry, companies and their products are often defined by the patents they hold. Having a second patent undeniably strengthens our product lines," says Davis.
Primary Technology has plans for a third patent submission this quarter. "Our third submission will include a unique technology which we feel will revolutionize the aesthetic light-based industry," says Stephen Almeida, President of Primary Technology.
About Primary Technology
Primary Technology develops, manufactures, and markets state-of-the-art proprietary intense pulsed light devices. Its systems are used in a variety of aesthetic applications, including, hair removal, non-invasive treatment of vascular lesions and pigmented lesions, for more information about the Company and its products, log on to
http://www.spectrapulse.com .
